Company Filing History:
Years Active: 2006
Title: The Innovations of Frederick Maloisel
Introduction
Frederick Maloisel is a notable inventor based in Illkirch Graffenstaden, France. He has made significant contributions to the field of medicine, particularly in the treatment of chronic myelogenous leukemia. His innovative approach has garnered attention in the scientific community.
Latest Patents
Maloisel holds a patent for a method of treating chronic myelogenous leukemia that is resistant or intolerant to ST1571. This treatment involves the use of homoharringtonine, either alone or in combination with other agents. The invention is particularly relevant for subjects suffering from this condition, with a preferred embodiment indicating that the subject is a human being.
Career Highlights
Frederick Maloisel is associated with Stragen Pharma SA, a company that focuses on developing innovative therapies. His work has contributed to advancements in cancer treatment, showcasing his dedication to improving patient outcomes.
Collaborations
Maloisel has collaborated with esteemed colleagues such as Jean-Pierre Robin and François-Xavier Mahon. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Frederick Maloisel's contributions to the treatment of chronic myelogenous leukemia highlight his innovative spirit and commitment to advancing medical science. His work continues to inspire future research and development in oncology.